Clinical Trial

Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to see if see if adding the specific combination of donors can result in acceptable levels of survival without evidence of disease.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2025-03-31; most recent amendment 2026-02-25.
Status change: Not Yet Recruiting → Recruiting 2025-08-04
Trial Details
NCT Number NCT06904482
Lead Sponsor Case Comprehensive Cancer Center
Conditions aGVHD, Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndromes
Enrollment 36 participants
Start Date 2025-08-13
Primary Completion 2027-02-24 (estimated)
Study Completion 2030-02-25 (estimated)
Updated on ClinicalTrials.gov 2026-02-27